Live·Open questions in longevity research
Hypothesis Universe
Omega Point · Hypothesis

may restart inflammation by combining in persistent

formed by of with damaged-tissue cells may restart inflammation. Persistent in where is reliably excluded, abolished by correcting , or , would reject this as the main explanation.

Stage of verification

  1. Hypothesis published2026-09-30
  2. Not enough research data
  3. Direct testAwaited

Map of the hypothesis

Hover over an icon or tap it to see its name.

Where in the body

Main connectionWhole body

Ageing mechanism

Main connectionGenomic instability

Direction

Kind of knowledge gap

A result exists, but its evidence is too fragile to rely on.Fragile gap

A double ring marks the main placement where a group contains several values.

Lens
Somatic cell fusion
Goal
Устойчивость восстановления к закреплению повреждённого состояния
Competing hypotheses
3
Published
2026-09-30
As a hypothesis
8 / 10Clarity of mechanism
8 / 10Few extra conditions
10 / 10Completeness of the answer
6 / 10Novelty of the idea
10 / 10Few new entities
8 / 10Decisive experiment
4 / 10Silver-bullet potential
Not ratedSupport from research
Poster: Fusion hypothesis predicts inflammatory relapse
PosterOpen the sheet full size2026-09-30

Target map

Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

  1. Harmful clone

    –tissue

    Cells formed by of cells with tissue cells, containing from both

    Where this hypothesis actsIn damaged tissues after the environment has normalized and useful is complete

    Hypotheses on this target 1
    Myeloid–tissue hybrid cellsClearance restoration. Hypotheses on this target 0Elimination. Hypotheses on this target 11Immunosuppression. Hypotheses on this target 0Population balance. Hypotheses on this target 0
    • Clearance restoration
    • Elimination1
    • Immunosuppression
    • Population balance

    What is proposed

    Elimination

    Selectively eliminate confirmed

    With whatNot stated in the record

    HowSelect with confirmed from both for removal after useful ; the removal technique is not stated

    Possible result

    Possible stabilization of and reduced inflammatory recurrence and repeated damage across organs

    From the recordИзбирательное устранение таких гибридов после завершения полезной регенерации должно стабилизировать SPV_6 и уменьшить повторное повреждение нескольких органов.

All targets of the lab

Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.

MoleculesAntibodies. Hypotheses on this target 3AntibodiesInterleukin-1α. Hypotheses on this target 3Interleukin-1αAmyloid seeds. Hypotheses on this target 2Amyloid seedsATP. Hypotheses on this target 2ATPCGRP. Hypotheses on this target 2CGRPHyaluronan. Hypotheses on this target 2HyaluronanInterleukin-1 receptor antagonist. Hypotheses on this target 2Interleukin-1 receptor antagonistInterleukin-6. Hypotheses on this target 2Interleukin-6Potassium. Hypotheses on this target 2PotassiumSpecialized pro-resolving lipid mediators. Hypotheses on this target 2Specialized pro-resolving lipid mediatorsAmmonia. Hypotheses on this target 1AmmoniaAntimicrobial peptides. Hypotheses on this target 1Antimicrobial peptidesBlood carbon dioxide. Hypotheses on this target 1Blood carbon dioxideBMP. Hypotheses on this target 1BMPCholesterol crystals. Hypotheses on this target 1Cholesterol crystalsCorticosterone. Hypotheses on this target 1CorticosteroneCryptic collagen ligands. Hypotheses on this target 1Cryptic collagen ligandsDKK1. Hypotheses on this target 1DKK1Double-stranded RNA. Hypotheses on this target 1Double-stranded RNAExtracellular electrolytes. Hypotheses on this target 1Extracellular electrolytesExtracellular histones. Hypotheses on this target 1Extracellular histonesFas ligand. Hypotheses on this target 1Fas ligandGlutamine. Hypotheses on this target 1GlutamineGlutathione. Hypotheses on this target 1GlutathioneHeavy chain–hyaluronan complexes. Hypotheses on this target 1Heavy chain–hyaluronan complexesHistamine. Hypotheses on this target 1HistamineInterleukin-10. Hypotheses on this target 1Interleukin-10Interleukin-22. Hypotheses on this target 1Interleukin-22Lipid A. Hypotheses on this target 1Lipid ALipid hydroperoxides. Hypotheses on this target 1Lipid hydroperoxidesM3 receptor autoantibodies. Hypotheses on this target 1M3 receptor autoantibodiesNAD+. Hypotheses on this target 1NAD+NKG2D ligands. Hypotheses on this target 1NKG2D ligandsNoggin. Hypotheses on this target 1NogginOxygen. Hypotheses on this target 1OxygenPeroxide. Hypotheses on this target 1PeroxidePGP-family peptides. Hypotheses on this target 1PGP-family peptidesPhenol-soluble modulins alpha (PSMα). Hypotheses on this target 1Phenol-soluble modulins alpha (PSMα)Phosphatidylserine. Hypotheses on this target 1PhosphatidylserinePlatelet-activating anti-PF4 immunoglobulin. Hypotheses on this target 1Platelet-activating anti-PF4 immunoglobulinProstaglandin E2. Hypotheses on this target 1Prostaglandin E2RNA–DNA hybrids. Hypotheses on this target 1RNA–DNA hybridsSenescent-cell secretions. Hypotheses on this target 1Senescent-cell secretionsSmall RNAs. Hypotheses on this target 1Small RNAsSoluble BCMA. Hypotheses on this target 1Soluble BCMAStratum corneum lipids. Hypotheses on this target 1Stratum corneum lipidsTacrolimus. Hypotheses on this target 1TacrolimusTGF-β1. Hypotheses on this target 1TGF-β1Tissue-binding antibodies. Hypotheses on this target 1Tissue-binding antibodiesTryptophan. Hypotheses on this target 1TryptophanTumstatin. Hypotheses on this target 1TumstatinVIP. Hypotheses on this target 1VIPWNT. Hypotheses on this target 1WNT
GenesRetroelements. Hypotheses on this target 3RetroelementsAcquired nuclear DNA. Hypotheses on this target 1Acquired nuclear DNAAntimicrobial protein coding sequences. Hypotheses on this target 1Antimicrobial protein coding sequencesExtrachromosomal DNA. Hypotheses on this target 1Extrachromosomal DNAHerpes simplex virus genomes. Hypotheses on this target 1Herpes simplex virus genomesHLA-II expression. Hypotheses on this target 1HLA-II expressionHormone-response regulatory variant combinations. Hypotheses on this target 1Hormone-response regulatory variant combinationsIFT88. Hypotheses on this target 1IFT88IRF4 half-site CpG methylation at the TGFB1 enhancer. Hypotheses on this target 1IRF4 half-site CpG methylation at the TGFB1 enhancerUV photolesions. Hypotheses on this target 1UV photolesions
Enzymes and receptorsProteases. Hypotheses on this target 7ProteasesEP2 receptor. Hypotheses on this target 5EP2 receptorGLS1. Hypotheses on this target 5GLS1YAP. Hypotheses on this target 5YAPmTOR. Hypotheses on this target 4mTORERK. Hypotheses on this target 3ERKFAK. Hypotheses on this target 2FAKGlutamine synthetase. Hypotheses on this target 2Glutamine synthetasemTORC1. Hypotheses on this target 2mTORC1Myosin. Hypotheses on this target 2MyosinNK1 receptor. Hypotheses on this target 2NK1 receptorp300. Hypotheses on this target 2p30012-lipoxygenase. Hypotheses on this target 112-lipoxygenaseAcid sphingomyelinase. Hypotheses on this target 1Acid sphingomyelinaseACOD1. Hypotheses on this target 1ACOD1Acyloxyacyl hydrolase. Hypotheses on this target 1Acyloxyacyl hydrolaseADAR1. Hypotheses on this target 1ADAR1AKT. Hypotheses on this target 1AKTAlpha-adrenergic receptors. Hypotheses on this target 1Alpha-adrenergic receptorsAMPK. Hypotheses on this target 1AMPKAntiproteases. Hypotheses on this target 1AntiproteasesApoptotic caspases. Hypotheses on this target 1Apoptotic caspasesβ-arrestin-2. Hypotheses on this target 1β-arrestin-2CAD. Hypotheses on this target 1CADCatalase. Hypotheses on this target 1CatalaseCathepsins. Hypotheses on this target 1CathepsinsCD1a. Hypotheses on this target 1CD1aCD40. Hypotheses on this target 1CD40CD45. Hypotheses on this target 1CD45CD47. Hypotheses on this target 1CD47Collagen IV. Hypotheses on this target 1Collagen IVCollagen VII. Hypotheses on this target 1Collagen VIIDermal collagen I and III triple helices. Hypotheses on this target 1Dermal collagen I and III triple helicesDNA polymerase theta. Hypotheses on this target 1DNA polymerase thetaEGFR. Hypotheses on this target 1EGFReIF2α. Hypotheses on this target 1eIF2αExecutioner caspases. Hypotheses on this target 1Executioner caspasesFactor XIII. Hypotheses on this target 1Factor XIIIFcγRIIa. Hypotheses on this target 1FcγRIIaFibrin. Hypotheses on this target 1FibrinFibronectin. Hypotheses on this target 1FibronectinFilamin C. Hypotheses on this target 1Filamin CFKBP12. Hypotheses on this target 1FKBP12FPR2/ALX receptor. Hypotheses on this target 1FPR2/ALX receptorβ-glucocerebrosidase. Hypotheses on this target 1β-glucocerebrosidaseGlucose-6-phosphate dehydrogenase. Hypotheses on this target 1Glucose-6-phosphate dehydrogenaseHCMV Fc-binding proteins. Hypotheses on this target 1HCMV Fc-binding proteinsHistones. Hypotheses on this target 1HistonesHsp70. Hypotheses on this target 1Hsp70HSPB1. Hypotheses on this target 1HSPB1Hyaluronan synthase 2. Hypotheses on this target 1Hyaluronan synthase 2Interleukin-10 receptor. Hypotheses on this target 1Interleukin-10 receptorIntestinal alkaline phosphatase. Hypotheses on this target 1Intestinal alkaline phosphataseKCC2. Hypotheses on this target 1KCC2LOX. Hypotheses on this target 1LOXM3 muscarinic receptor. Hypotheses on this target 1M3 muscarinic receptorMast-cell chymase. Hypotheses on this target 1Mast-cell chymaseMetabolic enzymes. Hypotheses on this target 1Metabolic enzymesMYC. Hypotheses on this target 1MYCMyeloperoxidase. Hypotheses on this target 1MyeloperoxidaseN-homocysteinylated circulating fibrinogen. Hypotheses on this target 1N-homocysteinylated circulating fibrinogenNeutrophil elastase. Hypotheses on this target 1Neutrophil elastaseNitric oxide synthase. Hypotheses on this target 1Nitric oxide synthaseNK3 receptor. Hypotheses on this target 1NK3 receptorNKG2D receptor. Hypotheses on this target 1NKG2D receptorNOTUM. Hypotheses on this target 1NOTUMORF2. Hypotheses on this target 1ORF2PAR1. Hypotheses on this target 1PAR1PCMT1. Hypotheses on this target 1PCMT1PD-1. Hypotheses on this target 1PD-1PD-L1. Hypotheses on this target 1PD-L1Peptide–MHC complexes. Hypotheses on this target 1Peptide–MHC complexesPhosphofructokinase. Hypotheses on this target 1PhosphofructokinasePIEZO1. Hypotheses on this target 1PIEZO1Prostaglandin E2 receptors. Hypotheses on this target 1Prostaglandin E2 receptorsRibosomes. Hypotheses on this target 1RibosomesRNase H1. Hypotheses on this target 1RNase H1SIRT6. Hypotheses on this target 1SIRT6TIM-4. Hypotheses on this target 1TIM-4TLR2. Hypotheses on this target 1TLR2TRPV4. Hypotheses on this target 1TRPV4TSG-6. Hypotheses on this target 1TSG-6V8 protease. Hypotheses on this target 1V8 proteaseZAKα. Hypotheses on this target 1ZAKα
CellsSenescent fibroblasts. Hypotheses on this target 7Senescent fibroblastsSenescent cells. Hypotheses on this target 4Senescent cellsOvarian somatic cells. Hypotheses on this target 3Ovarian somatic cellsT cells. Hypotheses on this target 3T cellsCooperating dangerous cells in breast tissue. Hypotheses on this target 2Cooperating dangerous cells in breast tissueMacrophages. Hypotheses on this target 2MacrophagesSenescent stromal cells. Hypotheses on this target 2Senescent stromal cellsAdrenal zona fasciculata cells. Hypotheses on this target 1Adrenal zona fasciculata cellsAntigen-presenting cells. Hypotheses on this target 1Antigen-presenting cellsAPC-altered cells. Hypotheses on this target 1APC-altered cellsBasal cells. Hypotheses on this target 1Basal cellsCapillary mural cells. Hypotheses on this target 1Capillary mural cellsCD1a-reactive T cells. Hypotheses on this target 1CD1a-reactive T cellsCompeting cells. Hypotheses on this target 1Competing cellsCorticotrophs. Hypotheses on this target 1CorticotrophsDendritic cells. Hypotheses on this target 1Dendritic cellsDifferentiated cells. Hypotheses on this target 1Differentiated cellsDll1-positive secretory progenitors. Hypotheses on this target 1Dll1-positive secretory progenitorsEpithelial progenitor cells. Hypotheses on this target 1Epithelial progenitor cellsFibroadipogenic progenitor cells. Hypotheses on this target 1Fibroadipogenic progenitor cellsFibroblasts. Hypotheses on this target 1FibroblastsGroup 3 innate lymphoid cells. Hypotheses on this target 1Group 3 innate lymphoid cellsHepatocytes. Hypotheses on this target 1HepatocytesIntestinal epithelial cells. Hypotheses on this target 1Intestinal epithelial cellsLgr5-positive stem cells. Hypotheses on this target 1Lgr5-positive stem cellsMast cells. Hypotheses on this target 1Mast cellsMature absorptive epithelial cells. Hypotheses on this target 1Mature absorptive epithelial cellsMedullary thymic epithelial cells. Hypotheses on this target 1Medullary thymic epithelial cellsMesenchymal stromal cells. Hypotheses on this target 1Mesenchymal stromal cellsMyeloid-biased long-term hematopoietic stem cells. Hypotheses on this target 1Myeloid-biased long-term hematopoietic stem cellsMyofibroblasts. Hypotheses on this target 1MyofibroblastsNeutrophils. Hypotheses on this target 1NeutrophilsNK cells. Hypotheses on this target 1NK cellsReparative cells. Hypotheses on this target 1Reparative cellsSenescent osteogenic cells. Hypotheses on this target 1Senescent osteogenic cellsStromal cells. Hypotheses on this target 1Stromal cellsThymic epithelial cells. Hypotheses on this target 1Thymic epithelial cellsTumor-reactive T cells. Hypotheses on this target 1Tumor-reactive T cellsMyeloid–tissue hybrid cells. Hypotheses on this target 1Myeloid–tissue hybrid cells
Tissues and matrixExtracellular matrix. Hypotheses on this target 11Extracellular matrixCollagen fibers. Hypotheses on this target 6Collagen fibersSkin tissue. Hypotheses on this target 4Skin tissueElastin–fibrillin network. Hypotheses on this target 3Elastin–fibrillin networkSubcutaneous adipose tissue. Hypotheses on this target 2Subcutaneous adipose tissueAntigen deposits. Hypotheses on this target 1Antigen depositsArterial resistance. Hypotheses on this target 1Arterial resistanceBasement membranes. Hypotheses on this target 1Basement membranesCell neighborhood geometry. Hypotheses on this target 1Cell neighborhood geometryCell surface geometry. Hypotheses on this target 1Cell surface geometryCorneocyte intercellular contacts. Hypotheses on this target 1Corneocyte intercellular contactsEpidermal mechanical stress. Hypotheses on this target 1Epidermal mechanical stressHyaluronan-proteoglycan matrix. Hypotheses on this target 1Hyaluronan-proteoglycan matrixMechanical prestress. Hypotheses on this target 1Mechanical prestressMotor units. Hypotheses on this target 1Motor unitsSensory axons. Hypotheses on this target 1Sensory axonsStratum corneum. Hypotheses on this target 1Stratum corneumStromal contacts. Hypotheses on this target 1Stromal contactsTendon tissue. Hypotheses on this target 1Tendon tissueTissue compression. Hypotheses on this target 1Tissue compressionTissue hydrostatic pressure. Hypotheses on this target 1Tissue hydrostatic pressureTissue mechanical relaxation spectrum. Hypotheses on this target 1Tissue mechanical relaxation spectrumVenous capacitance. Hypotheses on this target 1Venous capacitanceWet contact network between skin, clothing and bedding. Hypotheses on this target 1Wet contact network between skin, clothing and bedding
ProcessesEfferocytosis. Hypotheses on this target 8EfferocytosisSensory afferent activity. Hypotheses on this target 7Sensory afferent activityEpithelial barrier repair. Hypotheses on this target 6Epithelial barrier repairLipid peroxidation. Hypotheses on this target 6Lipid peroxidationProtein translation. Hypotheses on this target 6Protein translationCalcium phosphate mineral growth. Hypotheses on this target 4Calcium phosphate mineral growthInflammation resolution. Hypotheses on this target 4Inflammation resolutionInflammatory response. Hypotheses on this target 4Inflammatory responseVasomotor discharges. Hypotheses on this target 4Vasomotor dischargesActomyosin contraction. Hypotheses on this target 3Actomyosin contractionAntigen-receptor signaling. Hypotheses on this target 3Antigen-receptor signalingAntimicrobial immune functions. Hypotheses on this target 3Antimicrobial immune functionsCircadian phase distribution. Hypotheses on this target 3Circadian phase distributionMemory replay. Hypotheses on this target 3Memory replayMitophagy. Hypotheses on this target 3MitophagyScope inference. Hypotheses on this target 3Scope inferenceSleep continuity. Hypotheses on this target 3Sleep continuityThermal balance. Hypotheses on this target 3Thermal balanceTissue renewal timing. Hypotheses on this target 3Tissue renewal timingAntigen presentation. Hypotheses on this target 2Antigen presentationAntimicrobial memory. Hypotheses on this target 2Antimicrobial memoryAutophagy. Hypotheses on this target 2AutophagyBacteriophage replication. Hypotheses on this target 2Bacteriophage replicationBlood flow–sweat secretion synchrony. Hypotheses on this target 2Blood flow–sweat secretion synchronyBone remodeling. Hypotheses on this target 2Bone remodelingCell fusion. Hypotheses on this target 2Cell fusionCell proliferation. Hypotheses on this target 2Cell proliferationCell recruitment. Hypotheses on this target 2Cell recruitmentEndocrine fluctuations. Hypotheses on this target 2Endocrine fluctuationsFerroptosis. Hypotheses on this target 2FerroptosisGap junction communication. Hypotheses on this target 2Gap junction communicationOxidative capacity. Hypotheses on this target 2Oxidative capacityPolyploidization. Hypotheses on this target 2PolyploidizationPositional signaling. Hypotheses on this target 2Positional signalingTransepithelial water transport. Hypotheses on this target 2Transepithelial water transportAct-to-training handoff. Hypotheses on this target 1Act-to-training handoffActivator–inhibitor signaling. Hypotheses on this target 1Activator–inhibitor signalingAnabolism. Hypotheses on this target 1AnabolismAntibody–effector co-occupancy. Hypotheses on this target 1Antibody–effector co-occupancyAntigen cross-presentation. Hypotheses on this target 1Antigen cross-presentationAntigen processing. Hypotheses on this target 1Antigen processingAntimicrobial deployment–epithelial repair synchrony. Hypotheses on this target 1Antimicrobial deployment–epithelial repair synchronyAttention allocation. Hypotheses on this target 1Attention allocationAutomatic recommendation delivery. Hypotheses on this target 1Automatic recommendation deliveryAutonomic recovery. Hypotheses on this target 1Autonomic recoveryBacterial utilization of exogenous fatty acids. Hypotheses on this target 1Bacterial utilization of exogenous fatty acidsCalcium homeostasis. Hypotheses on this target 1Calcium homeostasisCalcium signal decoding. Hypotheses on this target 1Calcium signal decodingCandidate/source binding. Hypotheses on this target 1Candidate/source bindingCardiovagal baroreflex. Hypotheses on this target 1Cardiovagal baroreflexCargo-mediated pathogen transfer. Hypotheses on this target 1Cargo-mediated pathogen transferCathelicidin carbamylation. Hypotheses on this target 1Cathelicidin carbamylationCausal test-selection policy. Hypotheses on this target 1Causal test-selection policyCell competition. Hypotheses on this target 1Cell competitionCell-cycle entry. Hypotheses on this target 1Cell-cycle entryCell membrane repair. Hypotheses on this target 1Cell membrane repairCell survival signaling. Hypotheses on this target 1Cell survival signalingCellular–antibody response timing. Hypotheses on this target 1Cellular–antibody response timingCentrosome organization. Hypotheses on this target 1Centrosome organizationcGAS–STING signaling. Hypotheses on this target 1cGAS–STING signalingChromatin programme of chronic secretion. Hypotheses on this target 1Chromatin programme of chronic secretionCoagulation cascade. Hypotheses on this target 1Coagulation cascadeCollagen crosslinking. Hypotheses on this target 1Collagen crosslinkingColonocyte metabolism. Hypotheses on this target 1Colonocyte metabolismCommunicative planning. Hypotheses on this target 1Communicative planningCommunity-conditioned modification of reconstruction. Hypotheses on this target 1Community-conditioned modification of reconstructionCompeting action accessibility. Hypotheses on this target 1Competing action accessibilityCompetitive drug displacement. Hypotheses on this target 1Competitive drug displacementComplement cascade. Hypotheses on this target 1Complement cascadeConcurrent incompatible-update reconciliation. Hypotheses on this target 1Concurrent incompatible-update reconciliationConvention compatibility. Hypotheses on this target 1Convention compatibilityCue-to-intention binding. Hypotheses on this target 1Cue-to-intention bindingCulture-to-risk feedback. Hypotheses on this target 1Culture-to-risk feedbackCutaneous vasodilation. Hypotheses on this target 1Cutaneous vasodilationDefault-preserving meta-choice. Hypotheses on this target 1Default-preserving meta-choiceDNA integration. Hypotheses on this target 1DNA integrationDNA repair. Hypotheses on this target 1DNA repairDNA replication licensing. Hypotheses on this target 1DNA replication licensingEnactment-cost feedback. Hypotheses on this target 1Enactment-cost feedbackEndocrine–circadian phase relationship. Hypotheses on this target 1Endocrine–circadian phase relationshipEndothelium-dependent vasodilation. Hypotheses on this target 1Endothelium-dependent vasodilationEntity correspondence. Hypotheses on this target 1Entity correspondenceEpidermal sealing–dermal remodeling synchrony. Hypotheses on this target 1Epidermal sealing–dermal remodeling synchronyEpidermal turnover. Hypotheses on this target 1Epidermal turnoverER-selective autophagy. Hypotheses on this target 1ER-selective autophagyErythrocyte arrival timing. Hypotheses on this target 1Erythrocyte arrival timingExcitation–secretion coupling. Hypotheses on this target 1Excitation–secretion couplingExtracellular infectious particle stabilization. Hypotheses on this target 1Extracellular infectious particle stabilizationExtracellular vesicle clearance. Hypotheses on this target 1Extracellular vesicle clearanceFailure detection and handover. Hypotheses on this target 1Failure detection and handoverFibrinolysis. Hypotheses on this target 1FibrinolysisGlutamine–glutamate cycle. Hypotheses on this target 1Glutamine–glutamate cycleGYS1-NONO condensation. Hypotheses on this target 1GYS1-NONO condensationHexosamine biosynthesis. Hypotheses on this target 1Hexosamine biosynthesisHistone export. Hypotheses on this target 1Histone exportHorizontal nuclear DNA transfer. Hypotheses on this target 1Horizontal nuclear DNA transferHost oxidant production. Hypotheses on this target 1Host oxidant productionIgG Fc glycosylation. Hypotheses on this target 1IgG Fc glycosylationImmune surveillance. Hypotheses on this target 1Immune surveillanceImmune target discrimination. Hypotheses on this target 1Immune target discriminationInstruction-scope conversion. Hypotheses on this target 1Instruction-scope conversionInterpretation switching. Hypotheses on this target 1Interpretation switchingIntracellular protein clearance. Hypotheses on this target 1Intracellular protein clearanceKeratinocyte polarity. Hypotheses on this target 1Keratinocyte polarityLymphocyte–APC contact timing. Hypotheses on this target 1Lymphocyte–APC contact timingLysosomal membrane permeabilization. Hypotheses on this target 1Lysosomal membrane permeabilizationLysosomal peptidoglycan degradation. Hypotheses on this target 1Lysosomal peptidoglycan degradationLysosome reformation. Hypotheses on this target 1Lysosome reformationMacromolecular crowding. Hypotheses on this target 1Macromolecular crowdingMeal–activity timing. Hypotheses on this target 1Meal–activity timingMechanical interference among lymphocytes. Hypotheses on this target 1Mechanical interference among lymphocytesMechanical load–mitosis timing. Hypotheses on this target 1Mechanical load–mitosis timingMechanical loading. Hypotheses on this target 1Mechanical loadingMechanoradical production. Hypotheses on this target 1Mechanoradical productionMental accounting. Hypotheses on this target 1Mental accountingMicrobial chemical defense. Hypotheses on this target 1Microbial chemical defenseMitochondrial fusion. Hypotheses on this target 1Mitochondrial fusionMitochondrial maintenance. Hypotheses on this target 1Mitochondrial maintenanceMitochondrial proton leak. Hypotheses on this target 1Mitochondrial proton leakMitochondrial transfer. Hypotheses on this target 1Mitochondrial transferMitosis. Hypotheses on this target 1MitosisMitotic entry in basal keratinocytes. Hypotheses on this target 1Mitotic entry in basal keratinocytesMitotic synchrony. Hypotheses on this target 1Mitotic synchronyMnemonic retention demand. Hypotheses on this target 1Mnemonic retention demandMuscle fiber adaptation. Hypotheses on this target 1Muscle fiber adaptationMutagenesis. Hypotheses on this target 1MutagenesisNeurogenic vasodilation. Hypotheses on this target 1Neurogenic vasodilationNeurokinin signaling. Hypotheses on this target 1Neurokinin signalingNeuronal secretion. Hypotheses on this target 1Neuronal secretionNF-κB activation. Hypotheses on this target 1NF-κB activationNitrogen-processing reaction network. Hypotheses on this target 1Nitrogen-processing reaction networkOrganelle maintenance. Hypotheses on this target 1Organelle maintenanceOxidative metabolism. Hypotheses on this target 1Oxidative metabolismParacrine signal–response synchrony. Hypotheses on this target 1Paracrine signal–response synchronyPartner retention and sorting. Hypotheses on this target 1Partner retention and sortingPathogen export. Hypotheses on this target 1Pathogen exportPeptide conjugation. Hypotheses on this target 1Peptide conjugationPeroxide clearance. Hypotheses on this target 1Peroxide clearancePlatelet adhesion. Hypotheses on this target 1Platelet adhesionPost-injury illness cascades. Hypotheses on this target 1Post-injury illness cascadesPreference construction. Hypotheses on this target 1Preference constructionPrimary cilium assembly. Hypotheses on this target 1Primary cilium assemblyProspective time allocation. Hypotheses on this target 1Prospective time allocationProtein carbamylation. Hypotheses on this target 1Protein carbamylationPublic commitment to cultural propositions. Hypotheses on this target 1Public commitment to cultural propositionsReceptor signal integration. Hypotheses on this target 1Receptor signal integrationReciprocal phase resetting. Hypotheses on this target 1Reciprocal phase resettingRegeneration–immune recognition timing. Hypotheses on this target 1Regeneration–immune recognition timingRegulatory-cell cytotoxicity. Hypotheses on this target 1Regulatory-cell cytotoxicityRelational memory. Hypotheses on this target 1Relational memoryRenal tubular reabsorption. Hypotheses on this target 1Renal tubular reabsorptionRibosome assembly. Hypotheses on this target 1Ribosome assemblyRNA splicing. Hypotheses on this target 1RNA splicingScratch contact. Hypotheses on this target 1Scratch contactScratch motor program. Hypotheses on this target 1Scratch motor programSemantic rewriting. Hypotheses on this target 1Semantic rewritingSensory integration. Hypotheses on this target 1Sensory integrationSkin adhesion. Hypotheses on this target 1Skin adhesionSkin barrier repair. Hypotheses on this target 1Skin barrier repairSolar radiation absorption. Hypotheses on this target 1Solar radiation absorptionSource-conditioned reconstruction. Hypotheses on this target 1Source-conditioned reconstructionSpatial coordination of ERK signaling. Hypotheses on this target 1Spatial coordination of ERK signalingStromal cell–matrix mechanical coupling. Hypotheses on this target 1Stromal cell–matrix mechanical couplingSweat evaporation. Hypotheses on this target 1Sweat evaporationThermoregulatory feedback. Hypotheses on this target 1Thermoregulatory feedbackTissue growth. Hypotheses on this target 1Tissue growthTissue renewal cycles. Hypotheses on this target 1Tissue renewal cyclesTissue repair. Hypotheses on this target 1Tissue repairTranscription. Hypotheses on this target 1TranscriptionTranscription-factor partnerships. Hypotheses on this target 1Transcription-factor partnershipsTranscription–replication conflicts. Hypotheses on this target 1Transcription–replication conflictsTranscriptional priming in estrogen-responsive cells. Hypotheses on this target 1Transcriptional priming in estrogen-responsive cellsTranscriptional repression. Hypotheses on this target 1Transcriptional repressionTransdermal drug absorption. Hypotheses on this target 1Transdermal drug absorptionTransmission timing. Hypotheses on this target 1Transmission timingtRNA queuosine modification. Hypotheses on this target 1tRNA queuosine modificationUbiquitin-dependent proteasomal degradation. Hypotheses on this target 1Ubiquitin-dependent proteasomal degradationVariant competition and selection. Hypotheses on this target 1Variant competition and selectionVascular obstruction. Hypotheses on this target 1Vascular obstruction
Microbial communitiesGut microbiota. Hypotheses on this target 3Gut microbiotaBacterial pathogens. Hypotheses on this target 1Bacterial pathogens
MeasurementsCultural transmission mechanism classification. Hypotheses on this target 9Cultural transmission mechanism classificationMenopause syndrome classification. Hypotheses on this target 5Menopause syndrome classificationSweat secretory response. Hypotheses on this target 5Sweat secretory responseCircadian phase. Hypotheses on this target 2Circadian phaseCognitive performance measurements. Hypotheses on this target 2Cognitive performance measurementsNyquist stability boundary. Hypotheses on this target 2Nyquist stability boundaryRecovery status classification. Hypotheses on this target 2Recovery status classificationAntibody neutralizing activity. Hypotheses on this target 1Antibody neutralizing activityApplied shear load. Hypotheses on this target 1Applied shear loadCausal-binding accessibility. Hypotheses on this target 1Causal-binding accessibilityClone size measurement. Hypotheses on this target 1Clone size measurementContractile exit assessment. Hypotheses on this target 1Contractile exit assessmentFunctional performance measurements. Hypotheses on this target 1Functional performance measurementsInvasion measurement. Hypotheses on this target 1Invasion measurementMitotically reactivatable infected cell count. Hypotheses on this target 1Mitotically reactivatable infected cell countmt-Keima signal. Hypotheses on this target 1mt-Keima signalOptical oxygen saturation estimate. Hypotheses on this target 1Optical oxygen saturation estimatePerfusion measurements. Hypotheses on this target 1Perfusion measurementsSemantic coding. Hypotheses on this target 1Semantic codingSkin ageing index. Hypotheses on this target 1Skin ageing indexSkin microdamage classification. Hypotheses on this target 1Skin microdamage classificationSkin redness. Hypotheses on this target 1Skin rednessSkin water evaporation measurement. Hypotheses on this target 1Skin water evaporation measurementTarget-specific immune response measurements. Hypotheses on this target 1Target-specific immune response measurementsTreatment response classification. Hypotheses on this target 1Treatment response classificationViable pathogen burden. Hypotheses on this target 1Viable pathogen burden

Solid and named: the targets of this hypothesis

Explore in depth

The logic

The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.

The descent, in plain words

Inflammation may return even after the conditions around damaged tissue have recovered. The unexpected proposal is that an immune cell and a tissue cell could fuse, leaving one lasting cell that carries both sets of genetic material and restarts the response. This is a hypothesis generated by the pipeline, not a measured result.

The proposed mechanism, link by link
  1. An immune descendant of a blood-forming precursor fuses with a cell in damaged tissue.
  2. The resulting retains genetic material from both cell groups.
  3. Previously separate tissue and immune now operate within one persistent cell.
  4. The surroundings return to recovered conditions, but the retains the proposed inflammation-restarting activity.
  5. The releases inflammation-promoting substances and renews tissue injury.
  6. Selective removal of confirmed after useful repair is predicted to prevent inflammation from returning after another mild challenge.
A picture for it

Two separate alarm systems are rewired into one box that keeps sounding after the original fault has been repaired. Silencing both circuits could look like stopping two alarms that trigger each other, even though the trouble now sits inside one box.

Where the picture breaks: Cells do not have fixed wiring, and combining genetic material does not by itself establish a persistent inflammatory state. The picture explains the proposed location of the problem, not evidence that it exists.

  1. Master questionstep 01 of 04

    A shared cause of several aging processes could offer a way to improve several body systems through one targeted intervention.

    Rests on: The goal explicitly proposes that aging processes can reinforce one another and asks for ideas that target a common causal link.

    Stated in the chain
  2. Goal pillarstep 02 of 04

    Recovery should remain stable instead of giving way to a lasting damaged state.

    Rests on: The search for a shared cause is narrowed to whatever prevents recovery from lasting.

    Assumption

    The chain takes durable recovery as a candidate shared target without establishing that failure to maintain it drives aging across several systems.

  3. Gap questionstep 03 of 04

    Returning inflammation might originate in lasting changes within tissue cells, within that produce immune descendants, or in reinforcement between these groups. Temporarily suppressing their activity separately and together is proposed as a way to distinguish those possibilities.

    Rests on: The preceding stage identifies persistence of a damaged state as the problem to explain.

    Assumption

    The narrowing assumes that returning inflammation is a relevant form of failed recovery and that these two cell groups carry the lasting changes. The preceding stage does not establish either point.

  4. Hypothesisstep 04 of 04

    Persistent , meaning cells formed by of an immune cell with a damaged-tissue cell, are proposed to carry both groups' , their sets of genetic material. Their combined could restart , the release of substances that promote inflammation, after surrounding cells recover. Removing these after useful repair is predicted to prevent recurrence and reduce repeated injury in several organs.

    Rests on: The preceding question supplies the two candidate cell groups and the comparison between separate and combined suppression. The hypothesis places their activities inside one fused cell instead of requiring interaction between separate cells.

    Assumption

    The proposed carrier is a persistent fused cell whose combined genetic material sustains inflammation-promoting activity. That carrier is an explicit mechanistic assumption; neither the preceding question nor the supplied sources establishes it. Its status as a proposal is not itself a missing argument.

What is carried, and what is not. Two supplied examples illustrate the evidence boundary: S3, a 2020 Nature Cell Biology study, reports involving precursors of , the cells that break down bone, during mouse bone maintenance and repair, but not the proposed immune–tissue ; S7, a 2011 American Journal of Pathology study, reports a lack of shared nuclear location of human and mouse genetic material suggesting absence of in an injured newborn-mouse lung model receiving human , which does not exclude elsewhere. The screened material therefore bears on in related settings, but establishes neither the specific initiating nor any complete causal link in the proposed six-link sequence, and does not establish the sequence end to end.S3S7

Where the reasoning is carried by something unstated · 3
  • Goal pillar. The chain takes durable recovery as a candidate shared target without establishing that failure to maintain it drives aging across several systems.
  • Gap question. The narrowing assumes that returning inflammation is a relevant form of failed recovery and that these two cell groups carry the lasting changes. The preceding stage does not establish either point.
  • Hypothesis. The proposed carrier is a persistent fused cell whose combined genetic material sustains inflammation-promoting activity. That carrier is an explicit mechanistic assumption; neither the preceding question nor the supplied sources establishes it. Its status as a proposal is not itself a missing argument.
How a result here could mislead · 3
  • A cell carrying both could be mistaken for a even if the observation comes from two cells measured together, an engulfed cell, or label transfer in small membrane-bound packages. What closes it: The specified live recording of and subsequent reading of genetic material from individual cells must establish both cellular origins in a genuine single . The design explicitly requires excluding those alternative sources of double labeling.
  • A stronger effect of suppressing both cell groups' activities could be credited to mutual reinforcement between separate populations when both activities operate inside the same . What closes it: The source of returning must be assigned to genetically confirmed or separate cells after suppression is withdrawn. The design predicts that distinction, but does not specify how secretion will be assigned to individual cells.
  • Continued inflammation after attempted removal could be read as refuting the hypothesis even if removal was incomplete; conversely, reduced inflammation could reflect unintended removal of other cells. What closes it: and the identities of other removed cells must be verified. The specified control removing the same number of neighboring nonhybrid cells is needed to separate identity from the effect of losing cells generally.

What would make this wrong. Persistent recurrence in where has been reliably excluded, together with elimination of that recurrence by correcting one of the supplied rival mechanisms, would refute as the main explanation. Those rivals locate the persistent cause in altered spacing at cell contacts that impairs debris removal, faulty handling of the cell's own genetic messages, or inflammation-promoting fragments of the material surrounding cells.

What it would change. If the predictions held, one candidate shared cause of recurrent injury would be a persistent fused-cell population, and recovery research would have to distinguish cooperation between separate cells from combined activity inside a single cell. Selective removal after useful repair would become a supported intervention to investigate in that tested system. A result would still not establish benefits in old animals, prevention of injury across organs, or longer life; the proposed stability outcome called is not defined in the supplied material.

Sources read · 8

3 literature searches, 9 full texts, 1 abstract-only; 10 source(s) assessed against this question using the available text. A bounded search is not evidence of absence.

S1Background

Restorative macrophage-derived RNAseT2 stimulates muscle stem cell fusion via an SLK/N-WASP/actin bundling dependent axis. · Nature communications · 2026

“The present study did not explore how RNAseT2 may affect the programming of immune cells, but has explored the impact of secreted RNAseT2 on MuSC fusion.”

Does not settle: It does not establish fusion between myeloid descendants and damaged-tissue cells, persistent hybrid genomes, recurrent inflammatory secretion after environmental normalization, effects across organs, SPV_6, or selective elimination of hybrids.

S2Background

Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1. · Scientific reports · 2020

“Osteoclasts are large, multinucleated cells that resorb bone. They arise from the fusion of myeloid progenitor cells, a process which is facilitated by two cytokines, M-CSF and RANKL.”

Does not settle: The source does not establish fusion between myeloid descendants and damaged-tissue cells, persistent hybrid genomes, renewed inflammatory secretion after environmental normalization, recurrence across organs, SPV_6 effects, or selective elimination of such hybrids.

S3Partly answers it

Erythromyeloid progenitors give rise to a population of osteoclasts that contribute to bone homeostasis and repair. · Nature cell biology · 2020

“progenies of Cx3cr1 + yolk-sac macrophages provide long-lasting osteoclast precursors that participate in cell-cell fusion with local precursors and contribute to the postnatal bone remodeling in both physiological and pathological setting.”

Does not settle: Источник описывает слияние предшественников остеокластов при ремоделировании кости у мышей. Он не устанавливает слияние миелоидных клеток с клетками повреждённой ткани, сохранение патологического гибридного генома, возобновление воспалительной секреции после нормализации среды, повторное повреждение органов или эффект избирательного устранения гибридов.

S4Background

Interaction of hematopoietic CD34+ CD45+ stem cells and cancer cells stimulated by TGF‑β1 in a model of glioblastoma in vitro. · Oncology reports · 2018

“U87 glioblastoma cells have a complex system of communication, including adhesive intercellular contacts, areas of interdigitation with dissolution of the cytoplasm, cell fusion, communication microtubes and microvesicles.”

Does not settle: Источник не устанавливает образование устойчивых гибридов миелоидных потомков с клетками повреждённой ткани, сохранение объединённого генома, повторный запуск воспалительной секреции после восстановления среды, влияние на SPV_6 или эффект избирательного устранения таких клеток.

S6Background

Cell-surface phosphatidylserine regulates osteoclast precursor fusion. · The Journal of biological chemistry · 2018

“Bone-resorbing multinucleated osteoclasts that play a central role in the maintenance and repair of our bones are formed from bone marrow myeloid progenitor cells by a complex differentiation process that culminates in fusion of mononuclear osteoclast precursors.”

Does not settle: It does not establish fusion of myeloid progeny with damaged-tissue cells, persistent hybrid genomes, inflammatory reactivation after environmental normalization, effects across organs, SPV_6, or selective elimination of such hybrids.

S7Contradicts it

Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. · The American journal of pathology · 2011

“Lack of nuclear colocalization of human and murine genomic material suggested the absence of fusion.”

Does not settle: Источник описывает модель повреждения лёгких новорождённых мышей после введения человеческих CD34+ клеток. Он не устанавливает наличие или устойчивость гибридных клеток в других повреждённых тканях, их воспалительную секрецию после нормализации среды, влияние на SPV_6 или последствия их избирательного устранения.

S8BackgroundQuote unverified

Mitochondrion-targeted therapies for diabetic wound healing: from mechanism to therapeutic opportunity. · Burns & trauma · 2026

“Mitochrial transfer can occur through several mechanisms, including tunneling nanotubes (TNTs), extracellular vesicles (EVs), gap junctions (GJs), and cell fusion [ ].”

Does not settle: The source does not establish persistent tissue–myeloid hybrid cells, genomic fusion, recurrent inflammatory secretion after environmental normalization, selective hybrid-cell elimination, or effects on SPV_6 and multi-organ reinjury.

S9BackgroundAbstract only

[Cognitive Impairment as a Sequela of COVID-19: Pathophysiology and Prospects for Treatment]. · Rinsho shinkeigaku = Clinical neurology · 2023

“Persistent infection could lead to cognitive impairments through mechanisms such as neurotoxicity mediated by spike proteins, neuroinflammation induced by cytokines, and neuronal cell fusion (syncytia).”

Does not settle: Абстракт не устанавливает существование устойчивых гибридов миелоидных потомков с клетками повреждённой ткани, сохранение объединённого генома, повторный запуск воспалительной секреции после нормализации среды, действие совместного подавления программ, устранение гибридов, влияние на SPV_6 или повторное повреждение органов.

The gap this hypothesis explains

Something is claimed here, but it rests on evidence too thin to carry weight.

Does temporarily silencing memory in tissue cells, blood-forming cells, or both stop inflammation returning after conditions improve?

Original wording · exactly as the pipeline generated it
The gap question, as the engine wrote it

Что возвращает воспаление после нормализации среды: , память или их взаимное подкрепление, выявляемое раздельным и совместным этих программ?

What this question is asking

The question asks where lasting changes that might restart inflammation are stored. It compares memory within tissue cells, memory in the that produce immune cells, and a cycle in which these two sources keep reactivating each other. The proposed comparison is between temporarily suppressing each memory program separately and suppressing both together after the original harmful conditions have been corrected. The question assumes that memory of physical conditions in tissue cells and inherited memory of altered cellular chemistry have already been demonstrated separately, but that their interaction in an aged organism remains unresolved. Its intended measure of success is recovery toward a common stable condition over weeks, followed by limited remaining loss of function during repeated challenges over months; the supplied material does not specify the challenges or acceptable limits.

What the terms mean
Inflammation
A response involving immune cells and tissue signals to injury or harmful exposure. Here, the outcome is whether that response returns after the original harmful conditions are corrected.
Cellular or inflammatory memory
A lasting change caused by an earlier exposure that alters a cell's later behavior or the behavior of its descendants. It names a class of effects, not conscious memory or one universally defined program.
Tissue cells and autonomous tissue-cell memory
Tissue cells are cells within organs; the question contrasts them with blood-forming precursors. Autonomous memory would mean that a retained change within those tissue cells contributes to later behavior without continued exposure to the original trigger; it does not necessarily mean independence from every outside signal.
Blood-forming stem and precursor cells
Cells that give rise to blood cells, including immune cells. Stem cells can maintain their own population, while precursors are further along the path toward particular blood-cell types; memory in this compartment could affect subsequently produced cells.
Immune cells
Cells involved in defense and responses to damage. The question concerns whether their behavior reflects lasting changes in the cells that produced them.
Mechanical memory
A lasting cellular effect of earlier physical conditions, such as forces or the properties of surrounding material. The pipeline labels this component RL-1, but supplies no definition of that label or direct finding establishing the particular program.
Metabolism and inherited metabolic memory
Metabolism is the set of chemical processes through which cells obtain and use energy and materials. Inherited metabolic memory here means that effects of an earlier metabolic state persist in descendant cells, rather than inheritance between parents and offspring; the pipeline labels it RL-2 without defining that label.
Memory program and reversible suppression
A memory program is shorthand for cellular processes that maintain an exposure's lasting effects. Reversible suppression means temporarily reducing those processes and then allowing the suppressing effect to end; temporary improvement alone would not establish permanent removal of memory.
Mutual reinforcement
A cycle in which changes in one cell group help maintain or restore changes in another, which then acts back on the first. It is one of the possibilities being asked about, not a demonstrated relationship in the supplied evidence.
Environmental correction
Removal or correction of the harmful conditions thought to sustain inflammation. The input does not specify those conditions or a measurement confirming that they have been corrected.
Functional deficit
A remaining reduction in how well a tissue or organism works. The pipeline asks for this loss to remain limited, but supplies neither the function being measured nor its acceptable limit.
Epithelial cells
Cells that cover body surfaces and line internal spaces and organs. S3 identifies them as cells capable of acquiring memory.
Cell-surface signaling protein
A protein at a cell's surface that helps transmit signals into the cell when an activating partner binds. In S2, memory preserves such a protein, supporting continued responsiveness to activating signals.
Neutrophils
A type of immune cell produced from blood-forming cells. S8 measures their increased arrival in the abdominal cavity during a subsequent infection.
Candida albicans
The fungal species used for the earlier exposure and subsequent infection in S8. That result concerns a response to infection, rather than demonstrated spontaneous return of inflammation after environmental correction.
What the question takes for granted
Premise only partly supported
Mechanical memory in tissue cells and inherited metabolic memory in blood-forming precursors have been demonstrated separately, and their interaction in an aged organism has not been established.

Tissue cells are cells within an organ, while blood-forming precursors generate blood cells, including immune cells. The assumption is that the first group can retain effects of earlier physical conditions and the second can pass effects of altered cellular chemistry to its descendants. If established in the relevant setting, these would provide two distinct sources whose contributions to returning inflammation could be compared.

The sources support a narrower premise: lasting changes occur in some tissue-cell settings, and prior exposure of blood-forming cells can affect the responses of their descendants. S2 reports inflammatory memory in pancreatic cancer cells, and S3 reports that cells covering or lining body surfaces acquire memories in living organisms. S8 reports a changed response in immune cells descended from previously exposed blood-forming cells in mice. These findings do not establish the specific mechanical and inherited metabolic programs named in the pipeline statement, their persistence after environmental correction in aged organisms, or their mutual reinforcement. None of the supplied excerpts establishes their interaction; that limitation does not establish that the wider literature lacks such work.S2S3S8

The same question asked without the part nothing read establishes:

  • After harmful conditions are corrected, does temporarily suppressing lasting changes in tissue cells, blood-forming precursors, or both prevent inflammation from returning?
  • What evidence distinguishes tissue-cell memory from blood-forming-precursor memory as a source of returning inflammation after harmful conditions are corrected?
What turns on the answer
  • Tissue-cell memory sustains recurrence Under this outcome, tissue cells would retain the change that restarts inflammation after their surroundings improve. Suppressing that memory would prevent recurrence under the conditions examined, while suppressing memory only in blood-forming precursors would leave the tissue source active.
  • Blood-forming-precursor memory sustains recurrence Under this outcome, blood-forming precursors would continue producing immune cells with an altered response. Suppressing that precursor memory would prevent recurrence under the conditions examined, while suppressing tissue-cell memory alone would leave the continuing supply of altered immune cells.
  • Both memories reinforce each other Under this outcome, activity arising from either cell group would help restore the altered state in the other. Separate temporary suppression would therefore permit recurrence, whereas joint suppression could interrupt the cycle; persistence of that interruption after suppression ends would determine whether recovery lasts.
  • Neither proposed memory explains recurrence If recurrence continued despite effective joint suppression, these two memories would not sufficiently explain its return. The question's proposed choice between them would then leave the actual cause unresolved.
Why it matters

Correcting an ongoing source of inflammation and removing a lasting change caused by that source are different steps. If tissue cells retain a change that restarts inflammation, correcting their surroundings could leave that source of recurrence intact. If blood-forming precursors retain the relevant change, the immune cells they subsequently produce could instead carry the altered response forward. If the two sources reactivate each other, suppressing only one could allow the other to restore the cycle. These are conditional consequences of the question's proposed mechanism: confusing them could lead to mistaking temporary improvement for lasting recovery.

What is already established

RL-1 и RL-2 показаны раздельно; их взаимодействие в старом организме не установлено.

What would have to be true

После устранения стимула траектории сходятся за недели; остаётся ниже заданных границ при повторных нагрузках месяцами.

What is missing

Неизвестно, какая память восстанавливает патологическое состояние после коррекции среды и достаточно ли устранения одного источника для устойчивого общего эффекта.

The mechanism it proposes

The engine's own statement of the hypothesis, in full.

Возврат воспаления поддерживают устойчивые , возникшие при с клетками повреждённой ткани. Объединение помещает в одну клетку. После нормализации среды такой вновь запускает , даже когда окружающие клетки восстановились. Совместное подавление двух программ поэтому может действовать внутри и ошибочно восприниматься как доказательство взаимного подкрепления двух независимых . Предполагаемое общее представляет собой сохранение с патологическим сочетанием . Избирательное устранение таких после завершения полезной должно стабилизировать и уменьшить повторное повреждение нескольких органов.

Testing and possible results

The prediction that would tell it apart

A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.

После раздельного и совместного воспаление возвращается преимущественно из клеток, в которых подтверждены обеих . Удаление только этих клеток устраняет после повторной малой нагрузки; удаление такого же числа соседних этого эффекта не даёт. Обнаружение устойчивого в с надёжно исключённым и его устранение коррекцией , или опровергает гипотезу как основное объяснение.

States a measurable outcome; comparing rivals needs more conditions. The prediction specifies an observable cellular source of recurrent inflammation, contrasting outcomes of selective cell removal, and an explicit rejection condition. No rival prediction is supplied. Only a bench experiment would settle it.

What testing it would take

The engine's own read on whether this is testable with methods that already exist.

Начальная проверка возможна в с различимыми двух , и последующим . Совпадения двух недостаточно: необходимо исключить , и перенос меток . Избирательное удаление подтверждённых осуществимее сначала в ; потребует отдельной системы.

Other explanations

Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.

This hypothesis predicts

После раздельного и совместного воспаление возвращается преимущественно из клеток, в которых подтверждены обеих . Удаление только этих клеток устраняет после повторной малой нагрузки; удаление такого же числа соседних этого эффекта не даёт. Обнаружение устойчивого в с надёжно исключённым и его устранение коррекцией , или опровергает гипотезу как основное объяснение.

  • What would separate them

    Wider cell contacts may prevent enzyme exclusion, impair clearance and renew inflammation predicts: При одинаковых , , составе клеток и текущей среде изменение только длины меняет присутствие в контакте, и вероятность завершённого . Короткий контакт восстанавливает очистку и предотвращает последующее воспаление при сохранении прежних . Укорочение внеклеточной части должно отменять этот эффект, поскольку укороченная снова помещается в контакт. Отсутствие такой зависимости при подтверждённом изменении расстояния отвергает геометрическое объяснение.

  • What would separate them

    Underedited ribonucleic acid may sustain inflammation through an interferon feedback loop predicts: В очищенных после удаления иммунных клеток возвращению воспаления предшествуют рост конкретных недостаточно отредактированных и активация . Адресное разрушение этих или восстановление предотвращает ; вариант не предотвращает. Для доказательства хранения состояния краткое вмешательство должно давать эффект после своей отмены, а должна воспроизводимо восстанавливать образование причинных . Если нормализовано, но воспаление возвращается и устраняется только коррекцией контакта или , гипотеза отвергается.

  • Rival 03 of 03
    Matrix breakdown may restart inflammation through a peptide-driven feedback loop

    Not yet published.

    What would separate them

    Matrix breakdown may restart inflammation through a peptide-driven feedback loop predicts: ранее повреждённой ткани запускает привлечение в системе из клеток без прежней истории воздействия. Эффект исчезает после избирательного удаления и возвращается при добавлении в измеренной исходной концентрации. Замена клеток при сохранённом допускает ; химическая обработка при сохранённых клетках предотвращает его. Сохранение эффекта после подтверждённого удаления причинных , особенно при зависимости от или геометрии , опровергает гипотезу.

Why this is not the mainstream account

The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.

Empirical anchor

В восстановление после сопровождалось образованием клеток с донорским и хозяйским и изменением донорского . Это подтверждает возможность объединения , но не воспалительную функцию . [Vassilopoulos et al., Nature, 2003](https://www.nature.com/articles/nature01539).

Subfield revised

Биология и . Пересмотру подлежал бы учебный раздел « и »: часть долговременной памяти пришлось бы объяснять физическим объединением клеточных .

Testable surprise

Избирательное удаление редких генетически подтверждённых предотвращает возврат воспаления одновременно в нескольких органах, хотя прежнего воздействия в обычных тканевых и сохраняются.

Why this is not the mainstream account

клеток при известно, существуют и обзоры при старении. Радикальна более узкая гипотеза: являются необходимым источником возврата воспаления и объясняют эффект совместного подавления . Целевой поиск не выявил работы, утверждающей именно это. Исчерпывающее доказательство отсутствия такой публикации отсутствует; соответствие критерию новизны предварительное.

What stands behind it

Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.

This hypothesis states no figure and cites no study, so there is nothing here to trace.

CitationsCites nothingFiguresnone statedPredictionStates a measurable outcome; comparing rivals needs more conditionsTo refuteOnly a bench experiment would settle it

What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.

0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.